Clinical Trials Logo

Filter by:
NCT ID: NCT06318533 Recruiting - Autoimmune Diseases Clinical Trials

A Clinical Study of CD19 CAR NK Cells for the Treatment of Relapsed/Refractory B-cell Related Autoimmune Diseases

Start date: March 13, 2024
Phase: Early Phase 1
Study type: Interventional

A single arm, open-label pilot study is designed to determine the safety and effectiveness of anti-CD19 CAR NK cells (KN5501) in patients with relapsed/refractory B-cell related autoimmune diseases.15 patients are planned to be enrolled in the dose-escalation trial (6×10^9 cells, 9×10^9 cells). The primary objective of the study is to evaluation of the safety and feasibility of KN5501 for the treatment of relapsed/refractory B-cell related autoimmune diseases. The secondary objective is to evaluate the effectiveness of KN5501 for the treatment of relapsed/refractory B-cell related autoimmune diseases. The exploratory objective is to evaluate expansion, persistence and ability to deplete CD19 positive B cells of KN5501 in patients with relapsed/refractory B-cell related autoimmune diseases.

NCT ID: NCT06318364 Recruiting - Clinical trials for Delirium, Postoperative

Postoperative Delirium in the Post-anesthesia Care Unit

Start date: January 20, 2024
Phase:
Study type: Observational

This study aims to investigate the incidence of postoperative delirium (POD) in the PACU and analyze its influencing factors, in order to provide theoretical basis for early screening and intervention for high-risk POD population. Blood samples of some study subjects will be collected and analyzed using molecular detection methods to provide a basis and insights into the pathophysiological mechanisms of POD.

NCT ID: NCT06318351 Recruiting - Clinical trials for Delirium, Postoperative

Transcutaneous Acupoint Electrical Stimulation and Postoperative Delirium Delirium

Start date: February 1, 2024
Phase:
Study type: Observational [Patient Registry]

Investigating postoperative delirium in patients undergoing thoracoscopic lung resection surgery who have received or not received relevant transcutaneous acupoint electrical stimulation treatment preoperatively, observing postoperative recovery quality indicators, evaluating the necessity of treatment, and clarifying the potential mechanisms by which transcutaneous acupoint electrical stimulation may improve postoperative delirium.

NCT ID: NCT06318247 Recruiting - Clinical trials for Impacted Third Molar Tooth

Using Xenograft Combined With Barrier Membrane to Improve the Formation of Deep Periodontal Pockets

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

To evaluate the clinical effect of site preservation after third molars extraction by using tooth extraction of third molars with site preservation using bio-oss and bio-guide in preventing the formation of deep periodontal pockets in the distal of second molars.

NCT ID: NCT06318234 Recruiting - Rectal Cancer Clinical Trials

PET/MR Evaluation of Regression Grading After Neoadjuvant Therapy for Rectal Cancer

Start date: January 1, 2024
Phase:
Study type: Observational [Patient Registry]

This project aims to evaluate the role of 18F-FAPI combined with 18F-FDG PET/MRI imaging in quantitatively and accurately evaluating the grading of rectal cancer after SCRT neoadjuvant therapy in patients with advanced rectal cancer as the research object, with postoperative histopathological analysis as the reference index, and to assess the ability of patients to achieve pCR. A diagnostic model and evaluation system will also be constructed.

NCT ID: NCT06318156 Recruiting - Clinical trials for Lumbar Disc Herniation

Exploring the Distribution Patterns and Infrared Characteristics of Force-sensitive Acupoints in Different Lumbar Nerve Segments in Patients With LDH Based on "Press Quickly" Theory

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Utilizing the "responsive acupoint palpation" technique and infrared thermography, we investigated the distribution patterns of pressure-sensitive acupoints across different lumbar spinal segments in patients with lumbar disc herniation (LDH). Methodology: The Finger TPS tactile pressure measurement system was employed to conduct sensitivity examinations on the acupoints of the L1~L5 lumbar spine in 80 LDH patients (Group 1) and 80 healthy individuals (Group 2), applying a standardized force of 60N. When a sensation of comfort was elicited, the points were marked on a human cutaneous nerve segment map. We then utilized infrared thermography to collect and compare the temperature differences of the top 10 most frequently responsive acupoint areas in the experimental group against those in the control group.

NCT ID: NCT06317610 Recruiting - Ovarian Cancer Clinical Trials

Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids

Start date: January 1, 2022
Phase:
Study type: Observational

The present study aims to collect early bright field image of patient-derived organoids with ovarian cancer. By leveraging artificial intelligence, this study will seek to construct and refine algorithms that able to predict growth of ovarian cancer organoids.

NCT ID: NCT06317558 Recruiting - NSCLC Clinical Trials

Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy

NeoIM-Lung
Start date: March 1, 2024
Phase:
Study type: Observational

The goal of this observational study is to evaluate the efficacy and long-term clinical outcomes of different neoadjuvant immunotherapies in NSCLC patients using the real-world data. The main questions it aims to answer are: - What the best setting for immune checkpoint inhibitors as the neoadjuvant treatment? - How to determine the subgroups of patients benefit from neoadjuvant immunotherapy? Participants will receive neoadjuvant immunotherapy the study will analyze the real-world data.

NCT ID: NCT06317324 Recruiting - Surgery Clinical Trials

Compare the Prognostic Differences Between SBRT and Surgery for NSCLC Patients With Interlobular Fissure Invasion.

Start date: August 1, 2023
Phase:
Study type: Observational

The goal of this observational study is to compare the prognostic differences between SBRT and Surgery for NSCLC patients with interlobular fissure invasion. The main questions it aims to answer are: 1. Explore the survival differences. 2. Explore of the lung function changes before and after different treatments.

NCT ID: NCT06317298 Recruiting - Clinical trials for Renal Cell Carcinoma, Clear Cell, Somatic

Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy

Start date: February 21, 2024
Phase: N/A
Study type: Interventional

This study will assess the efficacy and safety profile of fruquintinib in combination with everolimus as second line therapy of clear cell renal cell carcinoma patients who progressed after immunotherapy and tyrosine kinase inhibitor.